Hinge Health, Inc. (HNGE) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated November 4, 2025, announces the financial results for Hinge Health, Inc. for the third quarter ended September 30, 2025. The Company, an emerging growth company incorporated in Delaware, operates as a digital health platform. A conference call to discuss these results was held on November 4, 2025.
Key Financial Metrics
The provided filing text serves as a notification of the results and does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. The text confirms that the Company issued a press release (Exhibit 99.1) containing these figures and non-GAAP reconciliations, but the values themselves are not present in this document.
Material Changes
The filing text does not provide specific comparative data or detail material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for year-over-year or quarter-over-quarter performance analysis.
Guidance, Outlook, and Risks
The Company utilized its investor relations website (ir.hingehealth.com) to post supplemental investor materials and comply with Regulation FD disclosure obligations. The filing notes that non-GAAP financial measures were discussed in the press release and conference call. No specific forward-looking guidance, risk factors, or unusual items are detailed within the text of this Form 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2025 revenue, net loss, and cash burn figures.
- Verify the reconciliation of non-GAAP financial measures to GAAP equivalents provided in the press release.
- Check the investor relations website for supplemental materials referenced under Item 7.01.
- Confirm the Company's status as an emerging growth company and any related accounting election impacts.